Health Technology
Spanish companies developing health technologies
Developing medical devices, diagnostics, and healthcare software platforms defines the health technology sector. Regulatory approval timelines and shifting Medicare reimbursement models constantly inject liquidity into these equities. Right now, Grifols, S.A. Class A tops trading volume. The table below organizes vital technical and fundamental data points.
Symbol | Mkt cap | Price | Chg % | Vol | Rel vol | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Analyst rating |
|---|---|---|---|---|---|---|---|---|---|---|
 GRFGrifols, S.A. Class A | 6.67 B EUR | 11.245 EUR | −0.31% | 2.22 M | 0.95 | 16.92 | 0.66 EUR | +51.93% | 1.68% | Buy |
 ROVILaboratorios Farmaceuticos Rovi, S.A. | 3.22 B EUR | 68.60 EUR | −0.65% | 202.56 K | 1.28 | 18.95 | 3.62 EUR | +39.34% | 1.22% | Buy |
 ALMAlmirall SA | 2.42 B EUR | 11.22 EUR | −0.18% | 155.54 K | 1.48 | 40.95 | 0.27 EUR | — | 1.36% | Buy |
 FAEFaes Farma, S.A. | 1.53 B EUR | 4.885 EUR | −0.51% | 94.82 K | 0.63 | 18.21 | 0.27 EUR | −20.49% | 2.12% | Buy |
 PHMPharma Mar SA | 1.19 B EUR | 65.40 EUR | −0.76% | 39.48 K | 0.77 | 16.69 | 3.92 EUR | +102.78% | 1.21% | Buy |
 RJFLABORATORIO REIG JOFRE, S.A. | 214.07 M EUR | 2.56 EUR | −0.39% | 2.57 K | 0.28 | 30.15 | 0.08 EUR | +4.56% | 0.75% | No rating |
 PRMPRIM, S.A. | 209.32 M EUR | 12.25 EUR | −0.81% | 1.55 K | 1.00 | 15.99 | 0.77 EUR | −10.44% | 3.47% | No rating |
 ORYOryzon Genomics SA | 196.04 M EUR | 2.332 EUR | −0.93% | 260.52 K | 1.17 | — | −0.03 EUR | +53.50% | 0.00% | Strong buy |
 NTHNaturhouse Health SA | 136.68 M EUR | 2.23 EUR | −1.33% | 78.04 K | 1.20 | 15.54 | 0.14 EUR | −15.89% | 12.43% | No rating |
 VYTVytrus Biotech SA | 112.03 M EUR | 13.70 EUR | −2.49% | 7.33 K | 3.04 | 25.55 | 0.54 EUR | +107.59% | 0.00% | Buy |
 PANGPangaea Oncology SA | 52.7 M EUR | 1.47 EUR | 0.00% | 0 | 0.00 | — | — | — | 0.00% | No rating |
 LABLabiana Health SA | 43.3 M EUR | 5.05 EUR | 0.00% | 0 | 0.00 | 23.68 | 0.21 EUR | +71.88% | 0.00% | No rating |
 BSTBiotechnology Assets SA | 15.94 M EUR | 0.201 EUR | −3.83% | 103 K | 0.23 | — | — | — | 0.00% | No rating |